Barclays Maintains Equal-Weight on Sabra Health Care REIT, Raises Price Target to $23
Baird Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $21
Sabra Health Care REIT (SBRA) Q2 2026 Earnings Call Transcript
Sabra Health Care REIT, Inc. 2026 Q2 - Results - Earnings Call Presentation
Sabra Health Care REIT (SBRA) Could Be 5% Below Fair Value Following AFFO And Outlook Reaffirmation
Raymond James Upgrades Sabra Health Care REIT to Market Perform
Sabra Health Care REIT Inc (SBRA) (Q2 2026) Earnings Call Highlights: Strong Senior Housing ...
Sabra Healthcare REIT Q2 Earnings Call Highlights
Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcript
Sabra Health Care REIT, Inc. Q2 2026 Earnings Call Summary
Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimates
Sabra Health Care REIT (NASDAQ:SBRA) Q2 Results Beat on Revenue and AFFO Despite Loan Loss Provision
Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance
Sabra Health Care REIT Lowers FY2026 FFO Guidance from $1.55-$1.59 to $1.53-$1.55 vs $1.55 Est
Sabra Health Care REIT Q2 FFO $0.39, Inline, Sales $235.866M Beat $219.689M Estimate
HPP vs. SBRA: Which Stock Is the Better Value Option?
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report
Baird Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $23
Truist Securities Maintains Buy on Sabra Health Care REIT, Raises Price Target to $24
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.